Maine 2023-2024 Regular Session

Maine Senate Bill LD1191

Introduced
3/16/23  
Refer
3/16/23  

Caption

An Act Regarding Transparency of Medical Billing

Impact

Passing LD1191 will modify state healthcare laws to improve the transparency of medical billing practices in Maine. By requiring healthcare providers to offer cost estimates and by limiting the timeframe for billing and collections, the law seeks to safeguard patients from potentially burdensome billing procedures. This change will significantly influence how healthcare entities handle financial communications with patients, setting a standard for transparency that could lead to more informed decisions by patients regarding their care options.

Summary

LD1191, also known as the Act Regarding Transparency of Medical Billing, aims to bring increased visibility and accountability to the medical billing process, especially for uninsured patients. The bill mandates that health care entities provide upfront estimates of total costs for medical services upon request, enhancing patient awareness of the financial aspects of their health care. Furthermore, if a service is billed for the first time more than one year after its occurrence, the responsible party is not obligated to pay that bill and cannot face collection actions for such late billing. This is intended to protect uninsured patients from unexpected financial burdens and ensure more equitable treatment in the healthcare system.

Sentiment

The sentiment around LD1191 appears to be generally positive among patient advocacy groups and those supporting healthcare reform. Proponents argue that this legislation will alleviate the financial strain on vulnerable populations by providing essential price information, thus fostering a fairer healthcare ecosystem. However, there may be contention from healthcare providers concerned about the practical implications of implementing these requirements, as they could complicate existing billing processes and potentially lead to reduced revenue streams for practices that struggle with delayed payments.

Contention

Notable points of contention include the potential administrative burden on healthcare providers to comply with the requirements of LD1191, especially regarding accurately estimating the costs of medical services in scenarios where such costs may be variable. Critics highlight that while the intention of the bill is commendable, the requirement for upfront pricing could be challenging in situations requiring immediate care, where cost estimates could be inherently uncertain. Balancing patient protections with the operational realities of healthcare provision will be crucial as discussions surrounding this bill continue.

Companion Bills

No companion bills found.

Previously Filed As

ME HB2241

Providing for hospital price transparency and for medical office price transparency.

ME HB6863

CAT Act of 2025 Centers for Medicare & Medicaid Services Auditor Transparency Act of 2025

ME HB6794

VA Medical Center Facility Transparency Act

ME HB1387

Division of Medicaid and Dept. of Human Services; revise provisions under the Transparency and Fraud Prevention Act.

ME SB198

Transparency Transactions Medical Care Entities

ME SB2370

AN ACT to provide for a legislative management study regarding prescription drug transparency reporting under the federal drug discount program.

ME SB2370

AN ACT to provide for a legislative management study regarding prescription drug transparency reporting under the federal drug discount program.

ME S3012

Creates Health Care Cost Containment and Price Transparency Commission, Office of Healthcare Affordability and Transparency, and hospital price transparency regulations.

ME A1729

Creates Health Care Cost Containment and Price Transparency Commission, Office of Healthcare Affordability and Transparency, and hospital price transparency regulations.

ME HB8684

Transparency in Billing Act of 2026

Similar Bills

No similar bills found.